Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer's knowledge, that:
(1) the Company's Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | |
Date: March 31, 2023 | By: | /s/ Peter Fernandes |
| | Peter Fernandes |
| | Chief Executive Officer |
| | (Principal Executive Officer) |
| | |
Date: March 31, 2023 | By: | /s/ Nicholas Laccona |
| | Nicholas Laccona |
| | Principal Financial & Accounting Officer |
| | (Principal Financial Officer) |